Peptide categories explained

What are the main classes of peptide therapy?

A patient-safe guide to peptide therapy classes, peptide-adjacent products, listed Peptide12 options, evidence limits, FDA-approved versus compounded status, and the questions to ask before online care.

Educational guideUpdated May 15, 2026

Class map

1

Start with the treatment goal: weight management, metabolic care, strength or recovery questions, sexual health, skin or scalp goals, energy or fatigue, or general longevity support.

2

Identify the active ingredient and category instead of relying on a vague “peptide” label: semaglutide, tirzepatide, sermorelin, bremelanotide/PT-141, NAD+, glutathione, GHK-Cu, or methylene blue are not interchangeable.

3

Separate FDA-approved branded products from compounded prescriptions and from investigational or research-use products. Compounded finished medications are not FDA-approved drug products.

4

Review route-specific safety: injection, oral, nasal, topical, troche, or cream each changes storage, side-effect questions, pharmacy quality checks, and follow-up.

5

Use clinician review for eligibility, labs or vitals when appropriate, medication interactions, pregnancy plans, side effects, cost, refills, and seller red flags before starting or switching classes.

Direct answer

Peptide therapy is not one treatment. Common online categories include GLP-1 or GIP/GLP-1 medicines for metabolic care, growth-hormone-axis peptides, melanocortin sexual-health medicines, topical cosmetic peptides, and peptide-adjacent longevity products. Each class has different evidence, risks, prescription rules, pharmacy requirements, and follow-up needs.

Metabolic class

Incretin medicines are the most evidence-heavy peptide-related class

Semaglutide and tirzepatide are peptide or peptide-like incretin medicines used in branded products such as Wegovy, Ozempic, Zepbound, and Mounjaro, with some patients also asking about compounded prescriptions. This class is different from cosmetic peptides, growth-hormone-axis peptides, and supplement-style longevity products because labeled uses, contraindications, GI side effects, diabetes context, pregnancy planning, and insurance rules can strongly affect fit.

  • Ask whether the discussion is about an FDA-approved branded product, an individualized compounded prescription, or an investigational option.
  • Review diabetes medicines, history of pancreatitis or gallbladder issues, kidney dehydration risk, pregnancy plans, oral contraceptive questions, surgery plans, and GI symptoms with the clinician.
  • Avoid no-prescription GLP-1 sellers, copied dosing charts, salt-form shortcuts, guaranteed weight-loss claims, or “research-use” products marketed for human use.

Hormone-axis and signaling class

Growth-hormone-axis and melanocortin peptides need different screening

Sermorelin discussions center on growth-hormone-axis questions, lab context such as IGF-1, sleep and recovery goals, and sports-testing considerations. PT-141/bremelanotide discussions center on sexual-health symptoms, blood-pressure and cardiovascular screening, and whether the question matches the approved bremelanotide label or an off-label compounded context. These categories should not be grouped into a generic “performance peptide” plan.

  • Ask which outcome is being evaluated, what baseline information is needed, and what would make the clinician decline or delay care.
  • Ask how blood pressure, cardiovascular history, pituitary history, glucose issues, fertility plans, medication lists, and sports-testing rules affect the decision.
  • Avoid stack recipes, “HGH replacement” promises, libido guarantees, hidden pharmacy sourcing, or influencer protocols that skip clinician review.

Topical and longevity-adjacent class

Cosmetic peptides and longevity products have narrower claim limits

GHK-Cu topical foam, NAD+ injection or nasal or topical formats, glutathione injections, and low-dose oral methylene blue are often discussed near peptide therapy, but they do not all share the same biology, legal status, evidence base, or route risks. Topical products should not be framed as disease treatments, and longevity or focus products should not be sold as guaranteed anti-aging, detox, energy, hair-growth, or cognitive outcomes.

  • Ask whether the product is topical, injectable, nasal, oral, or compounded, and what the label will show for active ingredient, route, storage, and follow-up.
  • Review allergies, skin irritation, asthma or sulfite sensitivity, G6PD status, serotonergic medicines, supplement overlap, liver or kidney history, and pregnancy context when relevant.
  • Be cautious with products that blur prescription medicines, supplements, cosmetics, and research chemicals into one “peptide stack.”

Patient safety checklist

Questions to ask when comparing peptide therapy classes

These points are educational and do not replace medical advice. A licensed clinician should review individual history, medications, risks, and state-specific availability before treatment.

✓

What is the active ingredient, and is it actually a peptide, a peptide-like medicine, a cofactor, a dye, a cosmetic ingredient, or a supplement-style product?

✓

Is the option FDA-approved for the goal being discussed, compounded under an individualized prescription, cosmetic-only, investigational, or not appropriate for direct purchase?

✓

Which Peptide12-listed product is relevant: semaglutide, tirzepatide, Wegovy, Ozempic, Zepbound, Mounjaro, sermorelin, PT-141/bremelanotide, glutathione, NAD+, GHK-Cu, or methylene blue?

✓

What baseline information matters for this class: weight, blood pressure, pulse, A1C, kidney or liver function, IGF-1, medication list, pregnancy plans, skin history, or symptom timeline?

✓

What side effects or warning signs should prompt routine portal messaging, same-day clinician guidance, pharmacy review, urgent care, emergency services, or poison control?

✓

How does route change the plan: injection supplies and sharps, nasal irritation, oral medication absorption, topical irritation, storage, refills, or pharmacy labeling?

✓

What would make this class a poor fit, require more records or labs, or need primary-care or specialist coordination first?

✓

Does the seller rely on no-prescription checkout, research-use labels, stack recipes, guaranteed outcomes, fake certificates, or unclear pharmacy sourcing?

FAQs

Short answers for patients

Are all peptide therapies the same type of treatment?

No. “Peptide therapy” is a broad umbrella. GLP-1 medicines, sermorelin, PT-141/bremelanotide, GHK-Cu topical products, NAD+, glutathione, and methylene blue have different mechanisms, evidence, routes, risks, and regulatory status.

Which peptide therapy class has the strongest clinical evidence?

For many patients, the strongest evidence among common online peptide-related options is in FDA-approved branded incretin medicines such as semaglutide and tirzepatide products for their labeled uses. That does not mean every patient qualifies, and compounded prescriptions require separate pharmacy-quality review.

Are compounded peptide medications FDA-approved?

No. Compounded finished medications are not FDA-approved drug products. A clinician may consider an individualized compounded prescription when appropriate, but patients should ask about the active ingredient, pharmacy sourcing, labeling, storage, follow-up, and safer alternatives.

Are NAD+, glutathione, GHK-Cu, and methylene blue all peptides?

No. They are often discussed near peptide or longevity care, but they are different categories. NAD+ is a coenzyme, glutathione is a tripeptide, GHK-Cu is a copper peptide used topically, and methylene blue is a small-molecule dye/medicine with important interaction and G6PD questions.

Can I combine different peptide classes?

Do not combine, stack, switch, or restart peptide therapies based on online charts or seller protocols. A clinician should review the active ingredients, routes, side effects, medication interactions, labs or vitals, and pharmacy labels before any combination is considered.

What class should I ask about first?

Start with the health goal and safety context, not a peptide name. Weight, metabolic health, recovery, sexual health, skin or scalp goals, energy, and focus questions each point to different products and screening steps. The clinician may also decide that non-peptide care or in-person evaluation is safer.

Sources and related reading

Peptide12 pages use conservative educational language and authoritative sources where possible.

Nature Signal Transduction and Targeted Therapy: Therapeutic peptides current applications and future directionsFDA: Human drug compoundingFDA: BeSafeRx online pharmacy informationDailyMed: Ozempic semaglutide labelDailyMed: Zepbound tirzepatide labelPeptide12: What are peptide medications?Peptide12: Peptide therapy glossaryPeptide12: Which peptide therapy is right for me?Peptide12: Peptide therapy treatment goalsPeptide12: Peptide therapy medication listPeptide12: Can you combine peptide therapies?Peptide12: Peptide therapy safetyPeptide12: How online peptide therapy works